Literature DB >> 17823646

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Glen B Baker, Bernard Sowa, Kathryn G Todd.   

Abstract

Entities:  

Keywords:  amine oxidase inhibitors; deprenyl; monoamine oxidase; phenelzine; semicarbazide-sensitive amine oxidase

Mesh：

Substances：

Year:  2007        PMID： 17823646      PMCID： PMC1963356     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  35 in total

1.  Effects of the antidepressant phenelzine on brain levels of gamma-aminobutyric acid (GABA).

Authors:  G B Baker; J T Wong; J M Yeung; R T Coutts
Journal:  J Affect Disord       Date:  1991-03       Impact factor: 4.839

Review 2.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

Review 3.  Amplification of inhibitory mechanisms in cerebral ischemia: an alternative approach to neuronal protection.

Authors:  A Shuaib; R Kanthan
Journal:  Histol Histopathol       Date:  1997-01       Impact factor: 2.303

4.  Neurotoxicity of reactive aldehydes: the concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines.

Authors:  Paul L Wood; M Amin Khan; Sarah R Kulow; Siddique A Mahmood; Joseph R Moskal
Journal:  Brain Res       Date:  2006-05-30       Impact factor: 3.252

5.  Protection against apoptosis by monoamine oxidase A inhibitors.

Authors:  W Malorni; A M Giammarioli; P Matarrese; P Pietrangeli; E Agostinelli; A Ciaccio; E Grassilli; B Mondovi
Journal:  FEBS Lett       Date:  1998-04-10       Impact factor: 4.124

6.  Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine.

Authors:  Paul L Wood; M Amin Khan; Joseph R Moskal; Kathryn G Todd; Véronique A M I Tanay; Glen Baker
Journal:  Brain Res       Date:  2006-10-05       Impact factor: 3.252

7.  4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake.

Authors:  J E Springer; R D Azbill; R J Mark; J G Begley; G Waeg; M P Mattson
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

Review 8.  Pharmacology of selegiline.

Authors:  M Gerlach; M B Youdim; P Riederer
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

9.  Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors.

Authors:  P H Yu; B A Davis; A A Boulton
Journal:  J Med Chem       Date:  1992-10-02       Impact factor: 7.446

10.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

Authors:  M Nibuya; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167
View more
  4 in total

1.  The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

Authors:  Shahrdad Lotfipour; Monica M Arnold; Derk J Hogenkamp; Kelvin W Gee; James D Belluzzi; Frances M Leslie
Journal:  Neuropharmacology       Date:  2011-03-23       Impact factor: 5.250

2.  Kinetics of Inhibition of Monoamine Oxidase Using Cymbopogon martinii (Roxb.) Wats.: A Potential Antidepressant Herbal Ingredient with Antioxidant Activity.

Authors:  R N Gacche; R U Shaikh; S M Chapole; A D Jadhav; S G Jadhav
Journal:  Indian J Clin Biochem       Date:  2011-03-02

3.  Azalysine analogues as probes for protein lysine deacetylation and demethylation.

Authors:  Blair C R Dancy; Shonoi A Ming; Romeo Papazyan; Christine A Jelinek; Ananya Majumdar; Yan Sun; Beverley M Dancy; William J Drury; Robert J Cotter; Sean D Taverna; Philip A Cole
Journal:  J Am Chem Soc       Date:  2012-03-12       Impact factor: 15.419

Review 4.  Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models.

Authors:  Eleni Stamoula; Spyridon Siafis; Ioannis Dardalas; Alexandra Ainatzoglou; Alkis Matsas; Theodoros Athanasiadis; Chrysanthi Sardeli; Konstantinos Stamoulas; Georgios Papazisis
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.